ARBUTUS BIOPHARMA CORPORATION — Cash Flow Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow↑+30.6% +$6M
$-13M
Free Cash Flow↑+100.0% +$86K
$0
Investing Cash Flow↑+58.8% +$6M
$16M
Financing Cash Flow↑+15.4% +$219K
$2M
Capex↓-100.0% -$86K
$0
Stock-Based Comp↓-22.7% -$370K
$1M
D&A↓-96.7% -$325K
$11K
SBC Allocated Expense↑+126.3% +$2M
$4M